Moesin overexpression is a unique biomarker of adenomyosis
article
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
Moesin was found to be significantly overexpressed and activated in adenomyosis lesions compared to normal endometrium, suggesting it as a unique biomarker.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Adenomyosis is characterized by extension of endometrial glands and stromal cells into the myometrium. Here we proved that 'moesin' is a unique biomarker of adenomyosis. We selected two cases of adenomyosis that had been surgically resected and fixed with formalin. Proteins were extracted from the infiltrating adenomyosis lesions and normal endometrium by tissue microdissection. The extracted proteins were examined using a LC-MS/MS system and the expression profiles of each region were compared. Two hundred and sixty proteins were detected, among which 73 were expressed more in adenomyosis than in normal endometrium. Among these proteins, we focused on overexpression of moesin in adenomyosis. Expression of moesin estimated semiquantitatively using an immunohistochemistry score was higher in adenomyosis than in normal endometrium. In particular, moesin was significanly overexpressed in stromal cells of adenomyosis than in those of normal endometrium. Relative to normal endometrium, moesin was also overexpressed at the RNA level in 9 of 14 cases of adenomyosis and at the protein level in all 14 cases. We also detected activated (phosphorylated) moesin in adenomyosis lesions. The present findings suggest that moesin is characteristically overexpressed and activated in adenomyosis, and that moesin activation may be related to extension of adenomyosis in the myometrium.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (24)
- Adenomyosis—A Result of Disordered Stromal Differentiation via openalex
- Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis via openalex
- Increased matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 secretion but unaffected invasiveness of endometrial stromal cells in adenomyosis via openalex
- Uterine stem cells: What is the evidence? via openalex
- W1982767024 via openalex
- W1987904612 via openalex
- W1989431683 via openalex
- W1989554594 via openalex
- W2001268629 via openalex
- W2036050820 via openalex
- W2036631473 via openalex
- W2047374251 via openalex
- W2074435907 via openalex
- W2104819208 via openalex
- W2114428497 via openalex
- W2117571855 via openalex
- W2122283753 via openalex
- W2143516059 via openalex
- W2159433767 via openalex
- W1486445524 via openalex
- W2170464877 via openalex
- W1974321895 via openalex
- W1976054233 via openalex
- W1982553798 via openalex
Cited by (5)
- Histopathological characteristics of adenomyosis: structure and microstructure 2023
- The Menstrual Endometrium: From Physiology to Future Treatments 2022
- Bioinformatics strategy for the screening of key genes to differentiate adenomyosis from endometriosis (Review) 2019
- The expression of moesin, p21-activated kinase 4 (PAK 4), matrix metalloproteinases (MMP 2, MMP 9), and CD34 in the eutopic and ectopic endometrium in adenomyosis 2018
- Adenomyosis 2017
Source provenance
- europepmc
- last seen: 2026-06-12T06:13:51.797165+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:35.150238+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK